Vesigel by UroGen Pharma for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer): Likelihood of Approval
Vesigel is under clinical development by UroGen Pharma and currently in Phase III for Non Muscle Invasive Bladder Cancer (NMIBC)…
